Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IPTACOPAN vs ISATUXIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IPTACOPAN vs ISATUXIMAB: Safety Overview

Metric IPTACOPAN ISATUXIMAB
Total FAERS Reports 468 3,972
Deaths Reported 23 454
Death Rate 4.9% 11.4%
Hospitalizations 88 2,449
Average Patient Age 48.8 yrs 66.7 yrs
% Female Patients 53.4% 42.9%
FDA Approval Date Dec 5, 2023 N/A
Manufacturer Novartis Pharmaceuticals Corporation Sanofi-Aventis U.S. LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription N/A